Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial

Paz-Ares Luis and Dvorkin Mikhail and Chen Yuanbin and Reinmuth Niels and Hotta Katsuyuki and Trukhin Dmytro and Statsenko Galina and Hochmair Maximilian J and Özgüroğlu Mustafa and Ji Jun Ho and Voitko Oleksandr and Poltoratskiy Artem and Ponce Santiago and Verderame Francesco and Havel Libor and Bondarenko Igor and Kazarnowicz Andrzej and Losonczy György and Conev Nikolay V and Armstrong Jon and Byrne Natalie and Shire Norah and Jiang Haiyi and Goldman Jonathan W and Kollaborációs szervezet: CASPIAN investigators and Somfay Attila and et al.: Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial.
LANCET, 394 (10212). pp. 1929-1939. ISSN 0140-6736 (2019)

Actions (login required)